Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | HPGD | P15428 | 4/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.73 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.73 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.61 |
| ▸ | TTR | P02766 | 3/20 | 0.61 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2520059 | 1.00 | ALDH1A1 (0.73) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| SCHEMBL2517134 | 0.93 | ALDH1A1 (0.68) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| SCHEMBL2517133 | 0.93 | ALDH1A1 (0.68) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| Stilbamidine SCHEMBL889782 | 0.85 | PRMT1 (1.00) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| Stilbamidine SCHEMBL208655 | 0.85 | PRMT1 (1.00) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| SCHEMBL2519127 | 0.85 | PTGS1 (0.62) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| SCHEMBL2519130 | 0.85 | PTGS1 (0.62) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| SCHEMBL2521983 | 0.84 | PRMT1 (0.79) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| Stilbamidine SCHEMBL3932459 | 0.83 | PRMT1 (0.95) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 | |
| Stilbamidine SCHEMBL871695 | 0.81 | PRMT1 (0.91) | ALDH1A1HPGDHSD17B10CYP2C19PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9861564-B2 | Valeric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT, LLC (US) | 2018-01-09 | — | — | US | disclosed |
| US-9782335-B2 | Malic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-10-20 | — | — | US | disclosed |
| EP-2445511-B1 | SKIN REPAIR COMPOSITIONS COMPRISING CIRCADIAN GENE ACTIVATORS AND A SYNERGISTIC COMBINATION OF SIRT1 GENE ACTIVATORS | ELC MAN LLC (US) | 2016-09-07 | — | — | EP | disclosed |
| US-20160229791-A1 | Malic Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-08-11 | — | — | US | disclosed |
| US-9358194-B2 | Succinic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2016-06-07 | — | — | US | disclosed |
| US-9295621-B2 | Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant | ELC MANAGEMENT LLC (US) | 2016-03-29 | — | — | US | disclosed |
| US-20160038389-A1 | Succinic Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-02-11 | — | — | US | disclosed |
| US-9180316-B2 | Butyric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-9162083-B2 | Linoleic and Linolenic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2015-10-20 | — | — | US | disclosed |
| US-20110250251-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | MAES DANIEL H | 2011-10-13 | — | — | US | disclosed |
| US-20100216879-A1 | Resveratrol Ferulate Compounds And Compositions | MAES DANIEL H | 2010-08-26 | — | — | US | disclosed |
| US-20100080845-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | MAES DANIEL H | 2010-04-01 | — | — | US | disclosed |
| US-20100028317-A1 | Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators | ELC MANAGEMENT LLC | 2010-02-04 | — | — | US | disclosed |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | ELC MANAGEMENT LLC | 2009-02-19 | — | — | US | disclosed |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | RB1, SIRT1, EP300 | ALDH1A1 608/4885HPGD 310/4885HSD17B10 1458/4885 |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | SQLE, SMURF1, PIK3R1 | ALDH1A1 3102/4885HPGD 1849/4885HSD17B10 646/4885 |
| US-20100216879-A1 | Resveratrol Ferulate Compounds And Compositions | FER, FOLR1, FOLR2 | ALDH1A1 1726/4885HPGD 1424/4885HSD17B10 1292/4885 |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | CUTA, ERCC1, OGG1 | ALDH1A1 527/4885HPGD 199/4885HSD17B10 757/4885 |
| US-20100028317-A1 | Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators | CRY1, PER2, SIRT1 | ALDH1A1 2290/4885HPGD 2617/4885HSD17B10 2716/4885 |
| US-20110250251-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | CUTA, ERCC1, OGG1 | ALDH1A1 527/4885HPGD 199/4885HSD17B10 757/4885 |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | CUTA, SUV39H1, RARA | ALDH1A1 717/4885HPGD 816/4885HSD17B10 125/4885 |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | SMURF1, CUTA, SMURF2 | ALDH1A1 3004/4885HPGD 2286/4885HSD17B10 1106/4885 |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | CUTA, LRAT, RARA | ALDH1A1 2717/4885HPGD 1446/4885HSD17B10 701/4885 |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | SMARCC1, RARG, RARA | ALDH1A1 2613/4885HPGD 599/4885HSD17B10 667/4885 |
| US-20100080845-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | CUTA, ERCC1, OGG1 | ALDH1A1 527/4885HPGD 199/4885HSD17B10 757/4885 |
| US-20160229791-A1 | Malic Acid Esters Of Resveratrol And Cosmetic Compositions | ME1, ME2, ME3 | ALDH1A1 295/4885HPGD 453/4885HSD17B10 129/4885 |
| US-20160038389-A1 | Succinic Acid Esters Of Resveratrol And Cosmetic Compositions | SUCNR1, SIRT1, SUCLA2 | ALDH1A1 588/4885HPGD 279/4885HSD17B10 201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.